Saturday, February 11, 2012

Site Search

Screening, MedChem and ADMET Europe 2008

Screening, MedChem and ADMET Europe 2008

19-20 February, Stockholm, Sweden

ScreeningEurope.com     MedChemEurope.com     ADMETEurope.com

Following the success of the past few years, Select Biosciences is proud to announce their 5th annual Screening Europe conference run concurrently with the 4th MedChem Europe and the inaugural ADMET Europe.

Alongside a shared exhibition of selected scientific posters and service providers, Select Biosciences is organising a two day event gathering some of the most influential players in the field from Europe, Asia and America.

The agendas will include world renowned speakers including :

Guido Zaman, Senior Director GPCR & Kinases, Molecular Pharmacology Unit, Organon BioSciences
Torsten Schöneberg, Professor of Molecular Biochemistry and Endocrinology, Institute of Biochemistry Medical Faculty, University of Leipzig
Peter Langer, Professor, Institute of Chemistry, University of Rostock
Aaron Beeler, Assistant Director, Centre for Chemical Methodology and Library Development, Boston University
Richard Walmsley, Professor of Genetics, University of Manchester
Alan Wilson, Vice President, Drug Metabolism, Pharmacokinetics and Toxicology, Lexicon Pharmaceuticals
And many more…
Lead optimisation towards novel drug discovery can be achieved with various screening methods. New targets and new strategies will be the center of the debates this year again during the twin-track Screening Europe conference.

Novel High-Throughput Platforms
Protein Kinases
Screening Automation and Miniaturisation
Label-Free Detection
Oncology Target Screening
GPCR’s
Cell-Based Assays and Assay Development
Absorption, distribution, metabolism, and excretion, are the four important criteria that influence levels and kinetics of drug, and allow predicting possible toxic effects or the performance and pharmacological activity of drug compounds in our metabolism. The inaugural ADMET Europe will develop ADMET research and applications in its sessions.

ADME Prediction
Optimisation of ADME Properties
Toxicology & Safety Pharmacology
Transporters in ADME
Finally, our 4th MedChem Europe will present identification, synthesis and development of new chemical entities suitable for therapeutic use.

Target Identification
Lead Optimisation
Platforms and Combinatorial Chemistry
High Throughput Synthetic Chemistry
To guarantee a high attendance at Europe’s largest conference dedicated to biomolecular screening, ADME-toxicology and medicinal chemistry. Select Biosciences will maintain their traditional low registration fees and group booking discounts.

All conference passes include entrance to sessions from any track, the exhibition, as well as conference documentation, lunch and refreshments

To further increase the value of their trip, delegates can opt to attend additional training courses and business tutorials while in Stockholm. Details of the many courses are available on ScreeningEurope.com, MedChemEurope.com and ADMETEurope.com.

About Select Conferences http://www.selectconferences.com/

The conferences division of Select Biosciences Ltd. is focused on organising specialist biomedical meetings each year. Experts from both academia and commerce are invited to present timely information from current research through to commercial implementation of new technologies. These events also provide a unique networking facility and the opportunity to reach a highly targeted scientific audience.